US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

72.44

+1.932.74%

Post-market: 72.580.1400+0.19%19:58 EDT

Volume:5.37M

Turnover:387.46M

Market Cap:224.66B

PE:29.15

High:72.67

Open:71.51

Low:71.35

Close:70.51

Loading ...

Overview Company News Filings

Q4 2024 AIM ImmunoTech Inc Earnings Call

Thomson Reuters StreetEvents

AstraZeneca PLC ADR Falls Tuesday, Underperforms Market

Top Midday Stories: Ford US Sales Fall 1.3% Year Over Year in Q1; Judge Denies Johnson & Johnson Unit's Bankruptcy Plan

MT Newswires Live

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

Market Chatter: Drugmakers Urge Trump to Phase in Pharma Tariffs Slowly

MT Newswires Live

FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients

AstraZeneca Says Investigational Drug Cuts LDL Cholesterol in Phase 2b Trial

MT Newswires Live

AstraZeneca PLC Stock Falls Monday, Outperforms Market

AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

AstraZeneca's Muscle-Invasive Bladder Cancer Treatment Gets FDA Approval

Astrazeneca Imfinzi Approved in US for Treatment of Muscle-Invasive Bladder Cancer

MT Newswires Live

Astrazeneca Receives Approval Recommendation for Calquence Combination Therapy in Europe

MT Newswires Live

AstraZeneca announces FDA approval of Imfinzi combination

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds?

AstraZeneca PLC ADR Outperforms Competitors On Strong Trading Day

AstraZeneca Rallies Friday, Outperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AZN/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZN\",,,,,undefined,":{"symbol":"AZN","market":"US","secType":"STK","nameCN":"AstraZeneca PLC","latestPrice":72.44,"timestamp":1746216000000,"preClose":70.51,"halted":0,"volume":5374453,"hourTrading":{"tag":"盘后","latestPrice":72.58,"preClose":72.44,"latestTime":"19:58 EDT","volume":212214,"amount":15348603.3138,"timestamp":1746230303453},"delay":0,"floatShares":3089219511,"shares":3101273230,"eps":2.484749,"marketStatus":"Market Closed","change":1.93,"latestTime":"05-02 16:00:00 EDT","open":71.51,"high":72.67,"low":71.345,"amount":387458290.3478,"amplitude":0.018792,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.484749,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":1,"adrRate":0.5,"listingDate":737179200000,"exchange":"NASDAQ","adjPreClose":70.51,"dividendRate":0.021397,"preHourTrading":{"tag":"盘前","latestPrice":71.53,"preClose":70.51,"latestTime":"09:29 EDT","volume":25037,"amount":1781788.4999179998,"timestamp":1746192575679},"postHourTrading":{"tag":"盘后","latestPrice":72.58,"preClose":72.44,"latestTime":"19:58 EDT","volume":212214,"amount":15348603.3138,"timestamp":1746230303453},"volumeRatio":0.8272096790786885,"impliedVol":0.2712,"impliedVolPercentile":0.592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZN\",,,,,undefined,":{"symbol":"AZN","floatShares":3089219511,"roa":"8.16%","roe":"19.79%","lyrEps":2.269354,"volumeRatio":0.8272096790786885,"shares":3101273230,"dividePrice":1.55,"high":72.67,"amplitude":0.018792,"preClose":70.51,"low":71.345,"week52Low":61.24,"pbRate":"5.47","psRate":"4.09","week52High":87.675,"institutionHeld":0.1738,"latestPrice":72.44,"eps":2.484749,"divideRate":0.021397,"volume":5374453,"delay":0,"ttmEps":2.484749,"open":71.51,"prevYearClose":65.52,"prevWeekClose":69.57,"prevMonthClose":71.79,"prevQuarterClose":73.5,"fiveDayClose":69.57,"twentyDayClose":73.92,"sixtyDayClose":70.935},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZN\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524710498","title":"Q4 2024 AIM ImmunoTech Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2524710498","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524710498?lang=en_us&edition=fundamental","pubTime":"2025-04-02 10:44","pubTimestamp":1743561897,"startTime":"0","endTime":"0","summary":"Thomas Equels; President, Chief Executive Officer, Executive Vice Chairman; AIM ImmunoTech Inc. Thank you, operator. I'd like to thank everyone for joining us this morning. I've been looking forward to this call because the progress we've made in the last several months underscores our commitment to advancing Ampligen across multiple areas of significant medical need. We're continuing to build meaningful momentum, both clinically and strategically, and I'm excited to walk through some of the recent highlights. To start, we recently announced plans to conduct a new clinical study evaluating Ampligen in combination with AstraZeneca's intranasal influenza vaccine FluMist. This study will explore this combination as a potential intranasal vaccine for influenza, including avian flu. We're honored that Dr. Paul Goepfert of the University of Alabama-Birmingham Medical Center will serve as principal investigator for this important","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-aim-immunotech-inc-024457708.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AIM","AIMI","AZN"],"gpt_icon":0},{"id":"2524124216","title":"AstraZeneca PLC ADR Falls Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2524124216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524124216?lang=en_us&edition=fundamental","pubTime":"2025-04-02 05:23","pubTimestamp":1743542580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The AstraZeneca PLC ADR  shed 1.22% to $72.60 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.87% to 17,449.89 and the Dow Jones Industrial Average  falling 0.03% to 41,989.96.This was the ADR's second consecutive day of losses.AstraZeneca PLC ADR closed 17.19% below its 52-week high of $87.68, which the company reached on August 30th.Despite its losses, the ADR outperformed some of its competitors Tuesday, as Eli Lilly & Co.  fell 2.50% to $805.23, Biogen Inc.  fell 3.52% to $132.03, and Johnson & Johnson  fell 7.59% to $153.25.Trading volume  remained 905,279 below its 50-day average volume of 5.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 1, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswir","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"gpt_icon":0},{"id":"2524146991","title":"Top Midday Stories: Ford US Sales Fall 1.3% Year Over Year in Q1; Judge Denies Johnson & Johnson Unit's Bankruptcy Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2524146991","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524146991?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:38","pubTimestamp":1743521927,"startTime":"0","endTime":"0","summary":"The Dow Jones Industrial Average and S&P 500 Index were down in late-morning trading Tuesday, while the Nasdaq Composite was up, as market participants awaited President Donald Trump's rollout of tari","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["F","QCOM","HMC","AZN","JNJ","GSK","LLY"],"gpt_icon":1},{"id":"2524917146","title":"AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2524917146","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524917146?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:31","pubTimestamp":1743514260,"startTime":"0","endTime":"0","summary":"AstraZenecaAZN announced that the FDA has approved its blockbuster drug, Imfinzi, for a bladder cancer indication in the United States.Imfinzi is approved in combination with gemcitabine and cisplatin as a neoadjuvant treatment for muscle-invasive bladder cancer , a type of bladder cancer that has spread into the muscle wall of the bladder. The regulatory filing for the drug was reviewed under the FDA’s Priority Review Pathway. This marks the first approval for Imfinzi for a bladder cancer indication.AstraZeneca’s Imfinzi, either as a monotherapy or in combination with chemotherapy, is presently approved for stage III non-small cell lung cancer, extensive-stage small cell lung cancer, locally advanced or metastatic biliary tract cancer and endometrial cancer that is mismatch repair deficient and in combination with Imjudo in unresectable hepatocellular carcinoma in some countries. The drug has also recently been approved for limited-stage small cell lung cancer in the United States and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazenecas-imfinzi-gets-fda-nod-133100339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2236285917.USD","CORT","LU2417539215.USD","BK4007","BK4588","BAYRY","LU0320765992.SGD","LU1559883803.SGD","DVAX","LU2462157665.USD","BK4585","BK4568","LU0109394709.USD","LU2456880835.USD","BK4532","LU1829250122.USD","LU0566484027.USD","BK4087","CHMP","LU0889565916.HKD","AZN"],"gpt_icon":0},{"id":"2524190169","title":"Market Chatter: Drugmakers Urge Trump to Phase in Pharma Tariffs Slowly","url":"https://stock-news.laohu8.com/highlight/detail?id=2524190169","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524190169?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:53","pubTimestamp":1743508412,"startTime":"0","endTime":"0","summary":"Pharmaceutical companies are pressing US President Donald Trump to implement upcoming tariffs on medical imports gradually to ease potential disruption and allow time to shift production, Reuters reported Tuesday, citing sources familiar with the matter.Trump is expected to announce new tariffs Wednesday, including for pharmaceuticals, Reuters added.While specific drug tariff details are not expected this week, Reuters quoted the sources as saying, the industry anticipates the levies are unavoidable and is advocating for a stepwise increase rather than an immediate 25% rate.Some drugmakers reportedly hope the Trump administration will launch a study to assess how such tariffs might be applied.Industry trade group PhRMA estimates that moving drug manufacturing to the US can take up to a decade and billions in investment, backing calls for a slower tariff rollout, the news agency reported.The White House did not immediately respond to MT Newswires' request for comment.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LLY","GSK","LU1974910355.USD","LU0096364046.USD","LU1061106388.HKD","LU0170899867.USD","LU0354030438.USD","LU1093756325.SGD","SG9999015952.SGD","LU0225771236.USD","LU2063271972.USD","LU1032466523.USD","IE00B1BXHZ80.USD","LU0061475181.USD","LU1674673691.USD","LU0321505868.SGD","LU0795875086.SGD","LU1929549753.HKD","LU2237443895.HKD","SG9999017495.SGD","LU2505996681.GBP","IE00B7SZLL34.SGD","LU0345770993.USD","JNJ","LU1244550577.SGD","LU1988902786.USD","LU1732800096.USD","LU2129689605.HKD","GSK.UK","LU1232071149.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BGHQF631.EUR","LU2360106947.USD","AZN","LU2357305700.SGD","LU2456880835.USD","LU1894683348.USD","LU1074936037.SGD","BK4532","IE000M9KFDE8.USD","LU2361045086.USD","LU2237443549.SGD","LU0306807586.USD","SGXZ51526630.SGD","PFE","LU0320765992.SGD","IE00B2B36J28.USD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2524097658","title":"FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2524097658","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524097658?lang=en_us&edition=fundamental","pubTime":"2025-04-01 02:36","pubTimestamp":1743446174,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration  on Monday approved AstraZeneca Plc's  Imfinzi in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzias adjuvant monotherapyafter radical cystectomy  for adult patients with muscle-invasive bladder cancer .The FDA approval was based on results from the NIAGARA Phase 3 trial.In a planned interim analysis, the Imfinzi-basedperioperative regimen demonstrated a 32% reduction in the risk of disease progression, recurrence, not undergoing surgery, or death versus the comparator arm.Also Read: AstraZeneca's Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients. Results from the key secondary endpoint of overall survival  showed that the Imfinzi-based perioperative regimen reduced the risk of death by 25% versus neoadjuvant chemotherapy with radical cystectomy.Concurrently, AstraZeneca'sCalquence in combination with bendamustine and rituximab was recommended for approval in the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-astrazenecas-imfinzi-first-183614282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","LU0109394709.USD","LU0889565916.HKD","LU1829250122.USD","LU2456880835.USD","OS","LU2462157665.USD","LU0320765992.SGD","BK4568","BK4585","BK4588","LU2417539215.USD","LU2236285917.USD","BK4007","AZN"],"gpt_icon":0},{"id":"2524973914","title":"AstraZeneca Says Investigational Drug Cuts LDL Cholesterol in Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524973914","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524973914?lang=en_us&edition=fundamental","pubTime":"2025-04-01 01:55","pubTimestamp":1743443758,"startTime":"0","endTime":"0","summary":"AstraZeneca  said Monday its investigational drug AZD0780 combined with standard-of-care statins reduced low-density lipoprotein, or LDL, cholesterol by 50.7% at 12 weeks in a phase 2b trial, with no need for fasting or food restrictions.Among participants receiving AZD0780 30mg, 84% reached the recommended LDL-C target of under 70 mg/dL, compared with 13% on statins alone, the company said.Elevated LDL-C is a known risk factor for serious cardiovascular conditions like heart attacks and strokes.AZD0780 was generally well tolerated in the trial, with similar rates of adverse events and treatment discontinuation between the treatment and placebo groups, according to the company.Price: 72.94, Change: -0.86, Percent Change: -1.16","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","BK4007","LU2462157665.USD","BK4588","LDL","LU2236285917.USD","LU0109394709.USD","LU1829250122.USD","LU2417539215.USD","LU0889565916.HKD","LU2456880835.USD","BK4568","AZN","BK4585"],"gpt_icon":0},{"id":"2524924407","title":"AstraZeneca PLC Stock Falls Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2524924407","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524924407?lang=en_us&edition=fundamental","pubTime":"2025-04-01 00:01","pubTimestamp":1743436860,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC shed 1.4% to SEK1,459.00 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 1.9% to 2,372.48.The stock's fall  snapped a two-day winning streak.The company closed SEK340.00 below its 52-week high of SEK1,799.00, which the company reached on September 3, 2024.Trading volume was 354,539, compared to the 50-day average trading volume of 297,797.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"gpt_icon":0},{"id":"2524292224","title":"AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524292224","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524292224?lang=en_us&edition=fundamental","pubTime":"2025-04-01 00:00","pubTimestamp":1743436800,"startTime":"0","endTime":"0","summary":"New late-breaking clinical trial data presented at ACC and published simultaneously in JACC show benefit of investigational medicine AZD0780 on top of standard of care. WILMINGTON, Del., March 31, 2025----Positive results from the PURSUIT Phase IIb trial for AstraZeneca’s AZD0780 demonstrated a statistically significant low-density lipoprotein cholesterol  reduction when administered on top of standard-of-care statin therapy, as compared with placebo.1,2 AZD0780 is an investigational once-daily oral PCSK9 inhibitor for patients currently not reaching their LDL-C lowering goal despite standard-of-care-lipid lowering therapies such as statins.1,2. Sharon Barr, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said: \"These new data reflect AZD0780’s ability to reduce LDL cholesterol in patients who need more options to manage their cholesterol and related risks when standard-of-care therapy is not enough. As a novel small molecule oral PCSK9 inhibitor that can be taken withou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azd0780-novel-oral-pcsk9-inhibitor-160000041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","LU2456880835.USD","LDL","LU2462157665.USD","LU2236285917.USD","LU0889565916.HKD","LU2417539215.USD","BK4585","BK4568","LU1829250122.USD","BK4007","AZN"],"gpt_icon":0},{"id":"2523792991","title":"JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2523792991","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523792991?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:40","pubTimestamp":1743428400,"startTime":"0","endTime":"0","summary":"J&J JNJ recently reported new positive data from the phase III MARIPOSA study, which compared the combination of Rybrevant and Lazcluze against AstraZeneca’s AZN Tagrisso in first-line EGFR-mutated non-small cell lung cancer .Data from the study suggests that the Rybrevant-Lazcluze combo significantly extends overall survival  in NSCLC patients with EGFR exon 19 deletions  or exon 21 L858R substitution  mutations.We remind investors that the MARIPOSA study already achieved its primary endpoint of statistically significant and clinically meaningful improvement in progression-free survival. Based on this data, J&J secured approval for the Rybrevant-Lazcluze combo in the above indication in the United States and European Union  last year.J&J Boasts Rybrevant-Lazcluze Combo as Next Standard of Care. Rybrevant also received approval for a third indication in the United States. Last year, the FDA approved the combination of Rybrevant and chemotherapy  for the first-line treatment of patients","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jnjs-rybrevant-lazcluze-combo-outshines-134000871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z3B42.SGD","LU0320765646.SGD","BK4581","LU0889565916.HKD","LU1162221912.USD","LU1221951129.SGD","LU1935042991.SGD","LU0912757837.SGD","JNJ","BK4568","LU0058720904.USD","IE00BJT1NW94.SGD","AZN","NVS","LU1057294990.SGD","IE00B19Z3581.USD","LU0208291251.USD","BK4532","IE00B7SZLL34.SGD","IE0034235303.USD","IE00B3T34201.USD","LU0889566641.SGD","LU1059921491.USD","IE00B2B36J28.USD","LU1674673428.USD","LU2430703251.USD","LU1929549753.HKD","BK4585","LU1894683348.USD","SG9999002232.USD","LU1914381329.SGD","LU1221951046.USD","BK4534","LU2236285917.USD","BK4533","LU2417539215.USD","LU0345769631.USD","LU0320765489.SGD","LU0203347892.USD","LU1244550494.USD","BK4588","LU0122379950.USD","LU1023059063.AUD","LU1066051498.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU1778281490.HKD","LU0211331839.USD","LU1261432733.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"1185252208","title":"Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1185252208","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185252208?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:38","pubTimestamp":1743428305,"startTime":"0","endTime":"0","summary":"Moderna Shares Down 14% Premarket After Report Top Vaccine Official Peter Marks Forced Out at FDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Moderna Shares Tumble After Report Top Vaccine Official Peter Marks Forced Out at FDA","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","OCGN","AZN","IBIO","BNTX","GSK","REGN","VIR","PFE","ABT","LLY","NVAX","SNY","VXRT","MRNA","VERU","JNJ","GILD"],"gpt_icon":1},{"id":"2523194805","title":"AstraZeneca's Muscle-Invasive Bladder Cancer Treatment Gets FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2523194805","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523194805?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:38","pubTimestamp":1743421080,"startTime":"0","endTime":"0","summary":"AstraZeneca's treatment for adults with muscle-invasive bladder cancer was approved in the U.S.The U.K. drugmaker said Monday that Imfinzi was approved by the Food and Drug Administration after AstraZeneca secured priority review for it, and that the approval was based on a Phase 3 trial. Specifically, approval was granted to it in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as a treatment after radical cystectomy, or surgery to remove the bladder.Imfinzi is also approved in Brazil. Regulatory applications are currently under review in the European Union, Japan and several other countries.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AstraZeneca's Muscle-Invasive Bladder Cancer Treatment Gets FDA Approval","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4568","LU2417539215.USD","LU2462157665.USD","LU1829250122.USD","BK4007","LU2236285917.USD","LU0109394709.USD","LU2456880835.USD","BK4585","AZN","LU0889565916.HKD","BK4588"],"gpt_icon":0},{"id":"2523891016","title":"Astrazeneca Imfinzi Approved in US for Treatment of Muscle-Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2523891016","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523891016?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:23","pubTimestamp":1743420201,"startTime":"0","endTime":"0","summary":"Astrazeneca  said Monday that its drug Imfinzi has been approved by the Food and Drug Administration to treat adult patients with muscle-invasive bladder cancer, in combination with other treatments.The specific therapy approved is for Imfinzi combined with gemcitabine and cisplatin as a neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after radical cystectomy.The approval for the drug, also called durvalumab, was granted after securing priority review and was based on results from a phase 3 trial in which it showed a 32% reduction in the risk of disease recurrence and a 25% reduction in death risk, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","LU2417539215.USD","LU2456880835.USD","AZN","BK4588","LU1829250122.USD","LU2236285917.USD","LU2462157665.USD","BK4007","LU0320765992.SGD","BK4568","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2523591031","title":"Astrazeneca Receives Approval Recommendation for Calquence Combination Therapy in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2523591031","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523591031?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:17","pubTimestamp":1743419847,"startTime":"0","endTime":"0","summary":"Astrazeneca  said Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval for Calquence, in combination with bendamustine and rituximab, as a treatment for adult patients with previously untreated mantle cell lymphoma.The company said the recommendation was based on the results of a phase 3 trial, where the combination therapy demonstrated over 16 months of progression-free survival improvement compared with chemoimmunotherapy alone.Astrazeneca also said no new safety signals were identified during the trial, and Calquence's safety and tolerability remained consistent with its known safety profile.The company is currently evaluating Calquence as a single treatment and in combination with standard-of-care chemoimmunotherapy for the treatment of multiple B-cell blood cancers, according to the statement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2456880835.USD","BK4007","LU0320765992.SGD","LU1829250122.USD","LU2236285917.USD","BK4585","BK4568","LU0109394709.USD","LU2417539215.USD","LU2462157665.USD","BK4588","AZN","LU0889565916.HKD"],"gpt_icon":0},{"id":"2523910799","title":"AstraZeneca announces FDA approval of Imfinzi combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910799","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910799?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:16","pubTimestamp":1743419811,"startTime":"0","endTime":"0","summary":"AstraZeneca’s (AZN) Imfinzi in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy aft...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-announces-fda-approval-of-imfinzi-combination?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-announces-fda-approval-of-imfinzi-combination?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4007","BK4568","LU1829250122.USD","AZN","LU0109394709.USD","LU2417539215.USD","LU2236285917.USD","LU0320765992.SGD","LU2456880835.USD","BK4585","LU0889565916.HKD","LU2462157665.USD"],"gpt_icon":0},{"id":"2523491061","title":"IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2523491061","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523491061?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"Based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death vs. neoadjuvant chemotherapy alone. WILMINGTON, Del., March 31, 2025----AstraZeneca’s IMFINZI  in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy  has been approved in the US for the treatment of adult patients with muscle-invasive bladder cancer .The approval was granted by the Food and Drug Administration  after securing Priority Review and was based on results from the NIAGARA Phase III trial which were presented during a Presidential Symposium at the 2024 European Society for Medical Oncology  Congress and simultaneously published in The New England Journal of Medicine.In the trial, patients were treated with four cycles of IMFI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imfinzi-durvalumab-approved-us-first-110000141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","BK4007","LU2456880835.USD","BK4006","NICE","LU2417539215.USD","LU0320765992.SGD","BK4124","VOD","BK4585","AZN","HCC","BK4588","BK4132","HSCT","CRT","BK4097","LU1829250122.USD","LU2462157665.USD","LU0109394709.USD","OS","BK4144","BK4213","BK4568","TEN","BK4566","LU2236285917.USD","BK4543","BK4023","LU0889565916.HKD","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"2523181539","title":"Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2523181539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523181539?lang=en_us&edition=fundamental","pubTime":"2025-03-31 17:31","pubTimestamp":1743413460,"startTime":"0","endTime":"0","summary":"Nvidia : Shares of the artificial-intelligence bellwether fell more than 3% in premarket trading. CoreWeave , the Nvidia-backed AI startup that went public last week, also fell before the bell.Tesla , Palantir : The auto and tech stocks were heavily traded premarket, both losing ground.Robinhood : Shares fell more than 5% ahead of the open, as bitcoin prices fell. The online brokerage gets a big chunk of its revenue from clients' cryptocurrency trades. Other crypto-focused stocks, including MicroStrategy  and Coinbase , dropped too.Renesas Electronics , Sumco , Tokyo Electron : The semiconductor companies were among the biggest losers in Japan, where the Nikkei 225 slumped. In Taiwan, Foxconn  and TSMC  dropped.Many of Europe's biggest stocks lost ground, including luxury companies LVMH  and Hermes , pharmaceutical companies Roche  and AstraZeneca  and global chip company ASML .This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/W","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"449cc4f57b8438a978a421912869bd9e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOD","NVDU","NVDX","LU0345774391.USD","LU1127390331.HKD","RHHBY","3NVD.UK","AZN","2NVD.UK","LU2456880835.USD","SGXZ23171101.USD","LU2242649171.HKD","TSYW.SI","LU1815333072.USD","NVD","LU1037948897.HKD","LU2168564149.EUR","NVDA","NVD3.UK","LU0345768740.USD","LVMUY","LU1935042215.USD","LU0354030511.USD","LU1989764748.USD","LU2552382058.USD","STRK","NVDD","TSLL","LU0061474960.USD","LU2065170008.USD","NVDY","SG9999014542.SGD","NVD2.UK","LU1852331112.SGD","SNVD.UK","NVDS","LU0077335932.USD","NVDS.UK","03165","LU0494093205.USD","NVIW.SI","LU1435385759.SGD"],"gpt_icon":1},{"id":"2523639541","title":"Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523639541","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523639541?lang=en_us&edition=fundamental","pubTime":"2025-03-29 05:23","pubTimestamp":1743197023,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC  stands against the other best ADR stocks.The recent political developments initiated by the Trump 2.0 regime have set the stage for a potential reversal of the aforementioned trends, which may drive relative outperformance of foreign markets and make ADRs attractive again. First, the Trump 2.0 tariff turmoil and massive cuts in federal spending are likely to cause an economic slowdown and thus cut the earnings growth potential of domestic companies. Second, the threat of tariffs imposed on the USA’s allies is already causing retaliatory measures, including the potential substitution of American products for European or Canadian alternatives . Third, Europe has recognized that the US has become a less reliable partner,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-azn-best-adr-stock-212343782.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","LU0109394709.USD","BK4585","USAW.SI","QID","LU0889565916.HKD","LU2236285917.USD","TQQQ","TSYW.SI","LU2456880835.USD","LU2462157665.USD","BK4007","LU2417539215.USD","NVIW.SI","BK4588","LU0320765992.SGD","SQQQ","MNQmain","LU1829250122.USD",".IXIC","BK4568","QLD","NQmain","USJW.SI","AZN"],"gpt_icon":1},{"id":"2523636949","title":"AstraZeneca PLC ADR Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2523636949","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523636949?lang=en_us&edition=fundamental","pubTime":"2025-03-29 05:22","pubTimestamp":1743196920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The AstraZeneca PLC ADR  rose 1.30% to $73.79 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.70% to 17,322.99 and Dow Jones Industrial Average  falling 1.69% to 41,583.90.This was the ADR's second consecutive day of gains.AstraZeneca PLC ADR closed 15.84% short of its 52-week high of $87.68, which the company reached on August 30th.The ADR outperformed some of its competitors Friday, as Eli Lilly & Co.  rose 0.10% to $822.51, Biogen Inc.  fell 1.40% to $138.37, and Johnson & Johnson  rose 0.36% to $163.71.Trading volume  remained 2.2 million below its 50-day average volume of 5.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 28, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall St","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"gpt_icon":0},{"id":"2523837816","title":"AstraZeneca Rallies Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2523837816","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523837816?lang=en_us&edition=fundamental","pubTime":"2025-03-29 01:07","pubTimestamp":1743181620,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.AstraZeneca PLC  shares rallied 1.96% to GBP114.16 Friday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index  falling 0.08% to 8,658.85.AstraZeneca PLC closed 14.73% below its 52-week high of GBP133.88, which the company achieved on September 3rd.Trading volume totaled 1.3 million, compared to the 50-day average of 2.8 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-29","symbol":"AZN","fiscalQuarterEnding":"2025/03","expectedEps":1.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"pre","actualEps":1.24},{"date":"2025-02-21","symbol":"AZN","amount":1.05,"announcedDate":"2025-02-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-21","defaultRemindTime":1740148200000,"name":"阿斯利康","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-24","payableDate":"2025-02-21","currency":"USD","dateTimestamp":1740114000000,"payDate":"2025-03-24"},{"market":"US","date":"2025-02-06","symbol":"AZN","fiscalQuarterEnding":"2024/12","expectedEps":1.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":1.05},{"market":"US","date":"2024-11-12","symbol":"AZN","fiscalQuarterEnding":"2024/09","expectedEps":1.01,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":1.04},{"date":"2024-08-09","symbol":"AZN","amount":0.5,"announcedDate":"2024-07-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-09","defaultRemindTime":1723210200000,"name":"阿斯利康","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-09","payableDate":"2024-08-09","currency":"USD","dateTimestamp":1723176000000,"payDate":"2024-09-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZN\",market:\"US\",,,undefined,":[{"executeDate":"2016-02-17","recordDate":"2016-02-19","paymentDate":"2016-03-21","value":0.93,"currency":"USD"},{"executeDate":"2016-08-10","recordDate":"2016-08-12","paymentDate":"2016-09-12","value":0.44,"currency":"USD"},{"executeDate":"2017-02-15","recordDate":"2017-02-17","paymentDate":"2017-03-20","value":0.93,"currency":"USD"},{"executeDate":"2017-08-09","recordDate":"2017-08-11","paymentDate":"2017-09-11","value":0.44,"currency":"USD"},{"executeDate":"2018-02-15","recordDate":"2018-02-16","paymentDate":"2018-03-19","value":0.93,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.6154,"hold":0.0769,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1744430400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AZN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AZN","date":"2025-05-02","current":28.51286,"percent":0.1133,"low":-196.839437,"twenty":32.645488,"median":40.694901,"eighty":70.207612,"high":1968.240717,"avg":105.449846,"sd":364.365073,"marketCap":221601942295.02},"quantilePoints":[{"date":"2020-05-08","current":91.757593,"twenty":33.810018,"median":41.817639,"eighty":64.047299,"marketCap":139655056517.41},{"date":"2020-05-15","current":90.61471,"twenty":33.810018,"median":41.817639,"eighty":64.3314,"marketCap":137915587379.85},{"date":"2020-05-22","current":94.488642,"twenty":33.810018,"median":41.817639,"eighty":64.766526,"marketCap":143811713694.17},{"date":"2020-05-29","current":91.303819,"twenty":33.810018,"median":41.828728,"eighty":64.996903,"marketCap":138964412815.2},{"date":"2020-06-05","current":92.409801,"twenty":33.810018,"median":41.905749,"eighty":65.495146,"marketCap":140647717765.34},{"date":"2020-06-12","current":88.601773,"twenty":33.810018,"median":42.104217,"eighty":67.891019,"marketCap":134851898165.53},{"date":"2020-06-19","current":90.514417,"twenty":33.810018,"median":42.174792,"eighty":68.436024,"marketCap":137762942001.19},{"date":"2020-06-26","current":89.870253,"twenty":33.810018,"median":42.303223,"eighty":68.737983,"marketCap":136782525607.4},{"date":"2020-07-02","current":92.427925,"twenty":33.810018,"median":42.437213,"eighty":69.042583,"marketCap":140675302740.49},{"date":"2020-07-10","current":92.718659,"twenty":33.810018,"median":42.708877,"eighty":69.343604,"marketCap":141117798226.05},{"date":"2020-07-17","current":99.322235,"twenty":33.810018,"median":42.808295,"eighty":69.589283,"marketCap":151168442039.6},{"date":"2020-07-24","current":95.408114,"twenty":33.810018,"median":42.978118,"eighty":69.943808,"marketCap":145211149956.52},{"date":"2020-07-31","current":68.468512,"twenty":33.810018,"median":43.076217,"eighty":70.038737,"marketCap":147070361983.16},{"date":"2020-08-07","current":67.562997,"twenty":33.810018,"median":43.188144,"eighty":70.038737,"marketCap":145125318295.06},{"date":"2020-08-14","current":67.098371,"twenty":33.810018,"median":43.384918,"eighty":70.038737,"marketCap":144127300491.42},{"date":"2020-08-21","current":67.475084,"twenty":33.810018,"median":43.553809,"eighty":70.038737,"marketCap":144936481167.69},{"date":"2020-08-28","current":67.998044,"twenty":33.810018,"median":43.671628,"eighty":70.038737,"marketCap":146059798146.29},{"date":"2020-09-04","current":64.280901,"twenty":33.810018,"median":43.915425,"eighty":70.038737,"marketCap":138075374440.25},{"date":"2020-09-11","current":65.824326,"twenty":33.810018,"median":43.983884,"eighty":70.038737,"marketCap":141390652748.24},{"date":"2020-09-18","current":69.221855,"twenty":33.810018,"median":44.188968,"eighty":70.038737,"marketCap":148688544713.05},{"date":"2020-09-25","current":66.553733,"twenty":33.810018,"median":44.383729,"eighty":70.038737,"marketCap":142957418917.99},{"date":"2020-10-02","current":66.662663,"twenty":33.810018,"median":44.572948,"eighty":70.038737,"marketCap":143191400097.07},{"date":"2020-10-09","current":66.953055,"twenty":33.810018,"median":44.833877,"eighty":70.038737,"marketCap":143815161541.86},{"date":"2020-10-16","current":64.839687,"twenty":33.810018,"median":45.033151,"eighty":70.038737,"marketCap":139275648167.86},{"date":"2020-10-23","current":63.312144,"twenty":33.810018,"median":45.462301,"eighty":70.038737,"marketCap":135994485474.97},{"date":"2020-10-30","current":61.469046,"twenty":33.810018,"median":45.948999,"eighty":70.038737,"marketCap":132035510158.58},{"date":"2020-11-06","current":58.661785,"twenty":33.810018,"median":46.231724,"eighty":69.998502,"marketCap":146478476162.56},{"date":"2020-11-13","current":59.760079,"twenty":33.810018,"median":46.231724,"eighty":69.851997,"marketCap":149220915141.86},{"date":"2020-11-20","current":58.100671,"twenty":33.810018,"median":46.231724,"eighty":69.58094,"marketCap":145077376135.16},{"date":"2020-11-27","current":54.42849,"twenty":33.810018,"median":46.231724,"eighty":69.343948,"marketCap":135907938310.72},{"date":"2020-12-04","current":56.342788,"twenty":33.810018,"median":46.231724,"eighty":69.221855,"marketCap":140687941772.31},{"date":"2020-12-11","current":56.704271,"twenty":33.810018,"median":46.231724,"eighty":69.042583,"marketCap":141590563706.2},{"date":"2020-12-18","current":53.257556,"twenty":33.810018,"median":46.231724,"eighty":68.737983,"marketCap":132984116876.27},{"date":"2020-12-24","current":51.42954,"twenty":33.810018,"median":46.231724,"eighty":68.628075,"marketCap":128419562786.63},{"date":"2020-12-31","current":52.566621,"twenty":33.810018,"median":46.231724,"eighty":68.505005,"marketCap":131258852901.26},{"date":"2021-01-08","current":53.297492,"twenty":33.810018,"median":46.231724,"eighty":68.340916,"marketCap":133083838200.57},{"date":"2021-01-15","current":54.250512,"twenty":33.810018,"median":46.231724,"eighty":68.152058,"marketCap":135463529694.98},{"date":"2021-01-22","current":55.860251,"twenty":33.810018,"median":46.231724,"eighty":67.837301,"marketCap":139483046174.97},{"date":"2021-01-29","current":54.013362,"twenty":33.810018,"median":46.231724,"eighty":67.597089,"marketCap":134871364067.04},{"date":"2021-02-05","current":52.499585,"twenty":33.810018,"median":46.231724,"eighty":67.475084,"marketCap":131091464291.89},{"date":"2021-02-12","current":42.481646,"twenty":33.810018,"median":46.026399,"eighty":67.083797,"marketCap":135771337221.21},{"date":"2021-02-19","current":41.615797,"twenty":33.810018,"median":45.920036,"eighty":66.813746,"marketCap":133004089019.12},{"date":"2021-02-26","current":39.726772,"twenty":33.810018,"median":45.20917,"eighty":66.662663,"marketCap":126966763856.01},{"date":"2021-03-05","current":38.882507,"twenty":33.808324,"median":44.906662,"eighty":66.12361,"marketCap":124268492718.61},{"date":"2021-03-12","current":39.690846,"twenty":33.808324,"median":44.636711,"eighty":65.784088,"marketCap":126851941792.25},{"date":"2021-03-19","current":40.522698,"twenty":33.808324,"median":44.473388,"eighty":65.224549,"marketCap":129510542855.95},{"date":"2021-03-26","current":41.19428,"twenty":33.810018,"median":44.279927,"eighty":64.996903,"marketCap":131656922094.72},{"date":"2021-04-01","current":40.740961,"twenty":33.810018,"median":44.17727,"eighty":64.775083,"marketCap":130208113091.4},{"date":"2021-04-09","current":41.073847,"twenty":33.808324,"median":43.952764,"eighty":64.342644,"marketCap":131272013845.01},{"date":"2021-04-16","current":41.895286,"twenty":33.808324,"median":43.829519,"eighty":64.272386,"marketCap":133897332132.29},{"date":"2021-04-23","current":43.015928,"twenty":33.808324,"median":43.622491,"eighty":64.049177,"marketCap":137478904953.89},{"date":"2021-04-30","current":35.178221,"twenty":33.808324,"median":43.552363,"eighty":63.927524,"marketCap":139903784314.35},{"date":"2021-05-07","current":35.713855,"twenty":33.808324,"median":43.372927,"eighty":63.927524,"marketCap":142034002903.86},{"date":"2021-05-14","current":36.578305,"twenty":33.808324,"median":43.217296,"eighty":63.927524,"marketCap":145471921978.13},{"date":"2021-05-21","current":38.04253,"twenty":33.808324,"median":43.055022,"eighty":63.927524,"marketCap":151295142362.51},{"date":"2021-05-28","current":37.667421,"twenty":33.808324,"median":42.981334,"eighty":63.927524,"marketCap":149803331492.43},{"date":"2021-06-04","current":37.668709,"twenty":33.808324,"median":42.916976,"eighty":63.927524,"marketCap":149808456584.88},{"date":"2021-06-11","current":38.832052,"twenty":33.808324,"median":42.773046,"eighty":63.927524,"marketCap":154435068990.32},{"date":"2021-06-18","current":38.18588,"twenty":33.808324,"median":42.622329,"eighty":63.927524,"marketCap":151865244858.85},{"date":"2021-06-25","current":39.023576,"twenty":33.808324,"median":42.398874,"eighty":63.927524,"marketCap":155196763903.69},{"date":"2021-07-02","current":39.976605,"twenty":33.808324,"median":42.174589,"eighty":63.927524,"marketCap":158986959728.24},{"date":"2021-07-09","current":39.480288,"twenty":33.808324,"median":42.080378,"eighty":63.927524,"marketCap":157013104025.95},{"date":"2021-07-16","current":37.956603,"twenty":33.808324,"median":41.899376,"eighty":63.927524,"marketCap":150953410117.19},{"date":"2021-07-23","current":45.441176,"twenty":33.808324,"median":41.888722,"eighty":63.927524,"marketCap":180719559415.33},{"date":"2021-07-30","current":47.231592,"twenty":33.810018,"median":41.892004,"eighty":63.861793,"marketCap":178110332974.09},{"date":"2021-08-06","current":46.469553,"twenty":33.810018,"median":41.892004,"eighty":63.713835,"marketCap":175236684168.41},{"date":"2021-08-13","current":47.972744,"twenty":33.810018,"median":41.892004,"eighty":63.551982,"marketCap":180905220248.64},{"date":"2021-08-20","current":48.844093,"twenty":33.810018,"median":41.892004,"eighty":63.422693,"marketCap":184191075201.21},{"date":"2021-08-27","current":48.365293,"twenty":33.810018,"median":41.892004,"eighty":62.883701,"marketCap":182385516153.02},{"date":"2021-09-03","current":48.463129,"twenty":33.811774,"median":41.895286,"eighty":62.612474,"marketCap":182754457617.81},{"date":"2021-09-10","current":46.494,"twenty":33.811774,"median":41.895286,"eighty":62.43589,"marketCap":175328870596.71},{"date":"2021-09-17","current":45.556592,"twenty":33.811774,"median":41.895286,"eighty":61.949531,"marketCap":171793907663.64},{"date":"2021-09-24","current":49.669587,"twenty":33.811774,"median":41.895286,"eighty":61.607974,"marketCap":187304013407.33},{"date":"2021-10-01","current":48.824353,"twenty":33.811774,"median":41.895286,"eighty":61.248398,"marketCap":184116632093.75},{"date":"2021-10-08","current":49.800513,"twenty":33.811774,"median":41.895286,"eighty":61.020009,"marketCap":187797735584.04},{"date":"2021-10-15","current":49.71937,"twenty":33.811774,"median":41.895286,"eighty":60.739134,"marketCap":187491745853.75},{"date":"2021-10-22","current":50.871053,"twenty":33.811774,"median":41.895286,"eighty":60.537147,"marketCap":191834739729.65},{"date":"2021-10-29","current":51.128224,"twenty":33.81353,"median":41.897331,"eighty":60.445661,"marketCap":192804535774.89},{"date":"2021-11-05","current":51.586876,"twenty":33.81353,"median":41.897331,"eighty":60.445661,"marketCap":194534108269.15},{"date":"2021-11-12","current":124.32333,"twenty":33.81353,"median":41.917192,"eighty":60.445661,"marketCap":182879619363.67},{"date":"2021-11-19","current":120.23438,"twenty":33.81353,"median":42.14268,"eighty":60.685883,"marketCap":176864773031.09},{"date":"2021-11-26","current":117.962901,"twenty":33.81353,"median":42.190627,"eighty":60.88723,"marketCap":173523426730.59},{"date":"2021-12-03","current":114.058101,"twenty":33.81353,"median":42.459679,"eighty":61.11746,"marketCap":167779466800.21},{"date":"2021-12-10","current":114.181064,"twenty":33.81353,"median":42.699465,"eighty":61.452265,"marketCap":167960345018.33},{"date":"2021-12-17","current":118.980811,"twenty":33.81353,"median":42.837881,"eighty":61.891111,"marketCap":175020772922.72},{"date":"2021-12-23","current":121.330793,"twenty":33.81353,"median":42.933402,"eighty":62.081355,"marketCap":178477596827.59},{"date":"2021-12-31","current":123.748715,"twenty":33.81353,"median":43.007672,"eighty":62.499235,"marketCap":182034359116.88},{"date":"2022-01-07","current":120.050561,"twenty":33.815286,"median":43.097412,"eighty":62.953761,"marketCap":176594376318.68},{"date":"2022-01-14","current":123.058267,"twenty":33.815286,"median":43.234717,"eighty":63.424083,"marketCap":181018710009.44},{"date":"2022-01-21","current":124.994373,"twenty":33.815286,"median":43.372927,"eighty":63.548212,"marketCap":183866722078.34},{"date":"2022-01-28","current":123.976416,"twenty":33.815286,"median":43.552363,"eighty":63.706505,"marketCap":182369309247.62},{"date":"2022-02-04","current":118.184057,"twenty":33.815286,"median":43.622491,"eighty":63.860585,"marketCap":173848748288.24},{"date":"2022-02-11","current":1601.026247,"twenty":33.817042,"median":43.82776,"eighty":64.00879,"marketCap":179314939563.19},{"date":"2022-02-18","current":1654.401018,"twenty":33.817042,"median":43.939798,"eighty":64.169686,"marketCap":185292914010.65},{"date":"2022-02-25","current":1668.738174,"twenty":33.817042,"median":44.078325,"eighty":64.295473,"marketCap":186898675368.11},{"date":"2022-03-04","current":1586.663703,"twenty":33.817042,"median":44.224518,"eighty":64.600266,"marketCap":177706334684.76},{"date":"2022-03-11","current":1675.474001,"twenty":33.817042,"median":44.467018,"eighty":65.166625,"marketCap":187653088130.53},{"date":"2022-03-18","current":1738.306661,"twenty":33.817042,"median":44.572948,"eighty":65.784088,"marketCap":194690345992.99},{"date":"2022-03-25","current":1795.841809,"twenty":33.817042,"median":44.572948,"eighty":66.489581,"marketCap":201134282573.26},{"date":"2022-04-01","current":1827.083488,"twenty":33.817042,"median":44.572948,"eighty":66.698379,"marketCap":204633350610.8},{"date":"2022-04-08","current":1968.240717,"twenty":33.817042,"median":44.599854,"eighty":66.956295,"marketCap":220442960330.62},{"date":"2022-04-14","current":1903.633793,"twenty":33.817042,"median":44.664609,"eighty":67.127776,"marketCap":213206984758.84},{"date":"2022-04-22","current":1827.31022,"twenty":33.817042,"median":45.008047,"eighty":67.494417,"marketCap":204658744606.77},{"date":"2022-04-29","current":-195.561143,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":207881494412.78},{"date":"2022-05-06","current":-186.047843,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":197768857946.09},{"date":"2022-05-13","current":-183.445869,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":195002958947.03},{"date":"2022-05-20","current":-190.668769,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":202680901868.49},{"date":"2022-05-27","current":-194.54477,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":206801090657.37},{"date":"2022-06-03","current":-190.374978,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":202368602400.22},{"date":"2022-06-10","current":-176.891963,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":188036156437.33},{"date":"2022-06-17","current":-176.59081,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":187716030487.33},{"date":"2022-06-24","current":-193.054847,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":205217301659.23},{"date":"2022-07-01","current":-188.578174,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":200458598457.74},{"date":"2022-07-08","current":-193.728763,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":205933674494.87},{"date":"2022-07-15","current":-192.228519,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":204338915909.36},{"date":"2022-07-22","current":-188.718222,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":200607469952.86},{"date":"2022-07-29","current":-163.162978,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":204443212506.84},{"date":"2022-08-05","current":-161.84855,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":202796233583.46},{"date":"2022-08-12","current":-160.589567,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":201218726783.29},{"date":"2022-08-19","current":-164.33585,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":205912819247.31},{"date":"2022-08-26","current":-165.535736,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":207416276963.04},{"date":"2022-09-02","current":-151.980645,"twenty":33.793274,"median":45.556592,"eighty":67.618433,"marketCap":190431747964.03},{"date":"2022-09-09","current":-150.350821,"twenty":33.759854,"median":45.556592,"eighty":67.618433,"marketCap":188389579323.08},{"date":"2022-09-16","current":-142.971469,"twenty":33.462713,"median":45.556592,"eighty":67.618433,"marketCap":179143250929.75},{"date":"2022-09-23","current":-135.412757,"twenty":33.234819,"median":45.556592,"eighty":67.618433,"marketCap":169672185276.98},{"date":"2022-09-30","current":-137.024975,"twenty":33.070312,"median":45.556592,"eighty":67.618433,"marketCap":171692293015.61},{"date":"2022-10-07","current":-137.934582,"twenty":32.990313,"median":45.556592,"eighty":67.618433,"marketCap":172832030829.71},{"date":"2022-10-14","current":-136.189836,"twenty":32.851802,"median":45.556592,"eighty":67.618433,"marketCap":170645864409.42},{"date":"2022-10-21","current":-134.729179,"twenty":32.794598,"median":45.556592,"eighty":67.618433,"marketCap":168815662212.36},{"date":"2022-10-28","current":-145.085703,"twenty":32.578746,"median":45.556592,"eighty":67.618433,"marketCap":181792385725.21},{"date":"2022-11-04","current":-150.046253,"twenty":32.441126,"median":45.556592,"eighty":67.618433,"marketCap":188007955286.73},{"date":"2022-11-11","current":94.735808,"twenty":32.406054,"median":46.033505,"eighty":67.825263,"marketCap":193261049543.38},{"date":"2022-11-18","current":98.881438,"twenty":32.406054,"median":46.253226,"eighty":68.270745,"marketCap":201718134504.01},{"date":"2022-11-25","current":100.570487,"twenty":32.406054,"median":46.494,"eighty":68.630373,"marketCap":205163794032.47},{"date":"2022-12-02","current":104.001851,"twenty":32.406054,"median":46.662739,"eighty":69.183829,"marketCap":212163775968.3},{"date":"2022-12-09","current":106.087706,"twenty":32.406054,"median":47.149871,"eighty":69.716808,"marketCap":216418920541.74},{"date":"2022-12-16","current":102.978508,"twenty":32.406054,"median":47.231592,"eighty":77.51575,"marketCap":210076156888.69},{"date":"2022-12-23","current":102.942288,"twenty":32.406054,"median":47.744626,"eighty":80.277721,"marketCap":210002267642.7},{"date":"2022-12-30","current":102.667462,"twenty":32.406054,"median":47.889649,"eighty":84.998822,"marketCap":209441622638.71},{"date":"2023-01-06","current":107.816944,"twenty":32.458836,"median":48.074276,"eighty":86.203785,"marketCap":219946565887.33},{"date":"2023-01-13","current":108.069807,"twenty":32.750787,"median":48.137803,"eighty":87.690545,"marketCap":220462406785.54},{"date":"2023-01-20","current":105.346185,"twenty":32.842448,"median":48.225012,"eighty":88.132026,"marketCap":214906218177.77},{"date":"2023-01-27","current":99.91328,"twenty":32.990313,"median":48.365293,"eighty":89.493625,"marketCap":203823092868.29},{"date":"2023-02-03","current":97.194847,"twenty":33.091636,"median":48.590919,"eighty":89.958492,"marketCap":198277488061.49},{"date":"2023-02-10","current":64.79374,"twenty":34.704276,"median":48.67565,"eighty":90.227834,"marketCap":213041815934.3},{"date":"2023-02-17","current":64.947931,"twenty":34.925603,"median":48.824353,"eighty":90.227834,"marketCap":213548799709.69},{"date":"2023-02-24","current":62.505092,"twenty":34.952202,"median":48.879329,"eighty":90.227834,"marketCap":205516742935.99},{"date":"2023-03-03","current":60.884824,"twenty":35.166348,"median":49.034331,"eighty":90.227834,"marketCap":200189300543.79},{"date":"2023-03-10","current":60.817416,"twenty":35.244416,"median":49.259346,"eighty":90.227834,"marketCap":199967660996.94},{"date":"2023-03-17","current":62.038789,"twenty":35.50748,"median":49.397527,"eighty":90.227834,"marketCap":203983536730.65},{"date":"2023-03-24","current":63.847982,"twenty":35.636896,"median":49.622888,"eighty":90.227834,"marketCap":209932167388.35},{"date":"2023-03-31","current":65.498173,"twenty":35.705258,"median":49.69358,"eighty":90.221194,"marketCap":215357992309.98},{"date":"2023-04-06","current":68.570831,"twenty":35.757541,"median":49.714558,"eighty":90.221194,"marketCap":225460889410.27},{"date":"2023-04-14","current":70.200873,"twenty":35.964313,"median":49.945228,"eighty":90.227834,"marketCap":230820471067.89},{"date":"2023-04-21","current":71.517248,"twenty":36.054882,"median":50.706874,"eighty":90.227834,"marketCap":235148709402.74},{"date":"2023-04-27","current":48.542146,"twenty":36.18562,"median":50.911319,"eighty":90.227834,"marketCap":228390801103.1},{"date":"2023-05-05","current":49.347014,"twenty":36.268071,"median":50.945363,"eighty":90.234475,"marketCap":232177702207.76},{"date":"2023-05-12","current":49.504739,"twenty":36.37963,"median":50.979408,"eighty":90.241115,"marketCap":232919796188.45},{"date":"2023-05-19","current":49.107772,"twenty":36.442091,"median":51.05333,"eighty":90.273874,"marketCap":231052066290.14},{"date":"2023-05-26","current":47.846336,"twenty":36.591375,"median":51.060903,"eighty":90.299991,"marketCap":225117008406.37},{"date":"2023-06-02","current":48.462782,"twenty":36.80131,"median":51.068476,"eighty":90.326109,"marketCap":228017386013.05},{"date":"2023-06-09","current":48.413705,"twenty":36.956644,"median":51.09835,"eighty":90.352226,"marketCap":227786482533.35},{"date":"2023-06-16","current":49.548607,"twenty":37.011895,"median":51.09835,"eighty":90.352226,"marketCap":233126199438.55},{"date":"2023-06-23","current":47.927025,"twenty":37.145966,"median":51.128224,"eighty":90.378344,"marketCap":225496652662.89},{"date":"2023-06-29","current":46.686861,"twenty":37.277576,"median":51.128224,"eighty":90.378344,"marketCap":219661682991.5},{"date":"2023-07-07","current":42.266477,"twenty":37.450916,"median":51.137896,"eighty":90.382517,"marketCap":198863776215.19},{"date":"2023-07-14","current":44.543915,"twenty":37.668194,"median":51.147569,"eighty":90.38669,"marketCap":209579116648.77},{"date":"2023-07-20","current":45.272526,"twenty":37.899674,"median":51.147569,"eighty":90.38669,"marketCap":213007237009.48},{"date":"2023-07-28","current":46.8505,"twenty":38.043422,"median":51.198971,"eighty":90.390862,"marketCap":220431604774.28},{"date":"2023-08-04","current":34.891689,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":215037480780.58},{"date":"2023-08-11","current":35.26449,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":217335048660.17},{"date":"2023-08-18","current":34.16614,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":210565921407.54},{"date":"2023-08-25","current":33.869471,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":208737548997.49},{"date":"2023-09-01","current":34.101255,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":210166031129.92},{"date":"2023-09-08","current":34.014193,"twenty":38.076047,"median":51.265357,"eighty":90.402485,"marketCap":209629465144.03},{"date":"2023-09-15","current":34.144205,"twenty":38.076047,"median":51.265357,"eighty":90.402485,"marketCap":210430732865.46},{"date":"2023-09-22","current":34.173978,"twenty":38.142274,"median":51.271456,"eighty":90.405762,"marketCap":210614226640.52},{"date":"2023-09-29","current":34.077187,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":210017704350},{"date":"2023-10-06","current":33.461697,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":206224433900},{"date":"2023-10-13","current":33.700939,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":207698886830.05},{"date":"2023-10-20","current":31.854117,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":196316921973.67},{"date":"2023-10-27","current":30.825604,"twenty":38.239617,"median":51.294062,"eighty":90.41603,"marketCap":189978199121.01},{"date":"2023-11-03","current":31.446977,"twenty":38.239617,"median":51.294062,"eighty":90.41603,"marketCap":193807722775.81},{"date":"2023-11-10","current":32.576944,"twenty":38.185708,"median":51.294062,"eighty":90.41603,"marketCap":192073660849.91},{"date":"2023-11-17","current":33.492327,"twenty":38.038501,"median":51.294062,"eighty":90.41603,"marketCap":197470761267.37},{"date":"2023-11-24","current":33.532656,"twenty":37.946854,"median":51.294062,"eighty":90.41603,"marketCap":197708536718.25},{"date":"2023-12-01","current":33.915355,"twenty":37.668451,"median":51.294062,"eighty":90.41603,"marketCap":199964933886.19},{"date":"2023-12-08","current":33.457568,"twenty":37.464611,"median":51.286265,"eighty":90.415594,"marketCap":197265816339.95},{"date":"2023-12-15","current":34.186234,"twenty":37.210418,"median":51.286265,"eighty":90.415594,"marketCap":201562040512.73},{"date":"2023-12-22","current":34.744053,"twenty":37.103714,"median":51.286265,"eighty":90.415594,"marketCap":204850936396.91},{"date":"2023-12-29","current":35.502272,"twenty":37.004613,"median":51.294062,"eighty":90.41603,"marketCap":209321397367.75},{"date":"2024-01-05","current":35.915235,"twenty":36.741256,"median":51.301859,"eighty":90.416466,"marketCap":211756222293.47},{"date":"2024-01-12","current":36.28455,"twenty":36.334148,"median":51.301859,"eighty":90.416466,"marketCap":213933708276.37},{"date":"2024-01-19","current":35.054357,"twenty":36.147608,"median":51.316432,"eighty":90.416903,"marketCap":206680482585.36},{"date":"2024-01-26","current":35.21195,"twenty":35.750631,"median":51.301859,"eighty":90.416466,"marketCap":207609659830.59},{"date":"2024-02-02","current":34.611292,"twenty":35.488516,"median":51.301859,"eighty":90.416466,"marketCap":204068178014.97},{"date":"2024-02-09","current":32.042332,"twenty":35.415951,"median":51.301859,"eighty":90.416466,"marketCap":190812082322.82},{"date":"2024-02-16","current":33.046703,"twenty":35.234976,"median":51.301859,"eighty":90.416466,"marketCap":196793117826.02},{"date":"2024-02-23","current":33.625836,"twenty":35.160006,"median":51.301859,"eighty":90.416466,"marketCap":200241851316.37},{"date":"2024-03-01","current":33.150124,"twenty":34.950737,"median":51.294062,"eighty":90.41603,"marketCap":197408989034.17},{"date":"2024-03-08","current":33.961877,"twenty":34.884115,"median":51.294062,"eighty":90.41603,"marketCap":202242978023.88},{"date":"2024-03-15","current":34.178971,"twenty":34.843983,"median":51.294062,"eighty":90.41603,"marketCap":203535777995.74},{"date":"2024-03-22","current":34.569497,"twenty":34.797981,"median":51.294062,"eighty":90.41603,"marketCap":205861353801.33},{"date":"2024-03-28","current":35.138443,"twenty":34.738617,"median":51.294062,"eighty":90.41603,"marketCap":209249428257.93},{"date":"2024-04-05","current":35.017877,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":208531458010.87},{"date":"2024-04-12","current":36.040239,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":214619626779.03},{"date":"2024-04-19","current":35.516317,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":211499662791.19},{"date":"2024-04-26","current":36.676755,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":232200540199.91},{"date":"2024-05-03","current":36.8693,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":233419536058.18},{"date":"2024-05-10","current":37.90429,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":239972059656.37},{"date":"2024-05-17","current":37.573079,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":237875168240.39},{"date":"2024-05-24","current":38.271406,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":242296270130.04},{"date":"2024-05-31","current":38.035274,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":240801317006.26},{"date":"2024-06-07","current":39.311051,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":248878266840.98},{"date":"2024-06-14","current":39.080088,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":247416040543.47},{"date":"2024-06-21","current":38.711485,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":245082412423.47},{"date":"2024-06-28","current":38.258325,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":242213457601.51},{"date":"2024-07-05","current":37.686159,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":238591075664.77},{"date":"2024-07-12","current":38.775783,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":245489481019.61},{"date":"2024-07-15","current":38.484698,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":243646624421.22},{"date":"2024-08-02","current":38.76335,"twenty":34.59882,"median":51.492254,"eighty":90.59886,"marketCap":249635972195.12},{"date":"2024-08-09","current":38.89894,"twenty":34.59882,"median":51.294062,"eighty":90.59886,"marketCap":250509172617.5},{"date":"2024-08-16","current":40.397147,"twenty":34.59882,"median":51.060903,"eighty":90.59886,"marketCap":260157622811.64},{"date":"2024-08-23","current":41.20613,"twenty":34.59882,"median":50.717669,"eighty":90.59886,"marketCap":265367483505.69},{"date":"2024-08-30","current":42.055252,"twenty":34.59882,"median":50.035509,"eighty":90.59886,"marketCap":270835826209.18},{"date":"2024-09-06","current":40.0627,"twenty":34.59882,"median":49.699751,"eighty":90.59886,"marketCap":258003788372.74},{"date":"2024-09-13","current":37.541027,"twenty":34.59882,"median":49.61335,"eighty":90.59886,"marketCap":241764208376.59},{"date":"2024-09-20","current":37.638672,"twenty":34.59882,"median":49.509177,"eighty":90.59886,"marketCap":242393042178.33},{"date":"2024-09-27","current":37.625615,"twenty":34.59882,"median":49.286663,"eighty":90.59886,"marketCap":242308957210.11},{"date":"2024-10-04","current":37.048339,"twenty":34.59882,"median":49.111103,"eighty":90.59886,"marketCap":238591303207.03},{"date":"2024-10-11","current":36.952592,"twenty":34.59882,"median":48.955607,"eighty":90.59886,"marketCap":237974690511.11},{"date":"2024-10-18","current":37.277326,"twenty":34.59882,"median":48.824043,"eighty":90.59886,"marketCap":240065978538.81},{"date":"2024-10-25","current":36.219041,"twenty":34.59882,"median":48.705135,"eighty":90.59886,"marketCap":233250622910.59},{"date":"2024-10-31","current":34.214563,"twenty":34.574738,"median":48.556466,"eighty":90.59886,"marketCap":220341789337.11},{"date":"2024-11-08","current":30.94958,"twenty":34.409381,"median":48.405215,"eighty":90.61471,"marketCap":199315297141.26},{"date":"2024-11-15","current":30.278774,"twenty":34.310083,"median":48.308272,"eighty":90.61471,"marketCap":196660634447.86},{"date":"2024-11-22","current":31.513145,"twenty":34.186234,"median":48.222861,"eighty":90.61471,"marketCap":204677872404.93},{"date":"2024-11-29","current":32.112113,"twenty":34.16614,"median":48.127581,"eighty":90.61471,"marketCap":208568177906.67},{"date":"2024-12-06","current":32.437834,"twenty":34.130516,"median":47.956432,"eighty":90.61471,"marketCap":210683725873.77},{"date":"2024-12-13","current":31.735912,"twenty":34.077187,"median":47.36104,"eighty":90.61471,"marketCap":206124752986.75},{"date":"2024-12-20","current":30.747177,"twenty":33.965862,"median":47.158831,"eighty":90.61471,"marketCap":199702915335.92},{"date":"2024-12-27","current":31.253559,"twenty":33.915355,"median":46.947642,"eighty":90.61471,"marketCap":202991871173.56},{"date":"2025-01-03","current":31.292576,"twenty":33.861252,"median":46.643867,"eighty":90.61471,"marketCap":203245281002.46},{"date":"2025-01-10","current":32.234446,"twenty":33.727001,"median":46.406597,"eighty":90.65359,"marketCap":209362728493.97},{"date":"2025-01-17","current":31.94661,"twenty":33.648774,"median":45.807185,"eighty":90.65359,"marketCap":207493237604.76},{"date":"2025-01-24","current":32.550101,"twenty":33.596764,"median":45.422812,"eighty":90.65359,"marketCap":211412903531.46},{"date":"2025-01-31","current":33.75602,"twenty":33.533107,"median":44.889475,"eighty":90.65359,"marketCap":219245348015.01},{"date":"2025-02-07","current":31.815023,"twenty":33.517373,"median":44.556858,"eighty":90.65359,"marketCap":223818687137.12},{"date":"2025-02-14","current":32.356027,"twenty":33.43473,"median":43.745721,"eighty":90.65359,"marketCap":227624649448.94},{"date":"2025-02-21","current":32.60623,"twenty":33.370464,"median":43.206289,"eighty":90.41603,"marketCap":229384833994.16},{"date":"2025-02-28","current":33.297502,"twenty":33.297026,"median":42.86189,"eighty":90.196276,"marketCap":234247926833.79},{"date":"2025-03-07","current":34.342579,"twenty":33.296549,"median":42.266477,"eighty":89.763533,"marketCap":241600044097.11},{"date":"2025-03-14","current":34.223161,"twenty":33.289955,"median":41.916906,"eighty":89.650259,"marketCap":240759931866.61},{"date":"2025-03-21","current":33.174158,"twenty":33.275366,"median":41.821537,"eighty":89.650259,"marketCap":233380202105.67},{"date":"2025-03-28","current":32.611493,"twenty":33.192075,"median":41.337415,"eighty":89.650259,"marketCap":229421855281.37},{"date":"2025-04-04","current":31.260761,"twenty":33.125053,"median":41.199067,"eighty":89.650259,"marketCap":219919458662.82},{"date":"2025-04-11","current":28.594151,"twenty":33.037318,"median":41.064599,"eighty":89.636216,"marketCap":201159849729.73},{"date":"2025-04-17","current":29.581448,"twenty":33.006368,"median":40.989973,"eighty":88.809353,"marketCap":208105481337.82},{"date":"2025-04-25","current":30.491371,"twenty":32.783239,"median":40.827536,"eighty":71.444046,"marketCap":214506794307},{"date":"2025-05-02","current":28.51286,"twenty":32.645488,"median":40.694901,"eighty":70.207612,"marketCap":221601942295.02}],"updateTime":1746323304463}}}